Eris Lifesciences Share Price

Eris Lifesciences Share Price

NSE: ERIS
|
Pharmaceuticals
|
S Cap
₹ 1,361.40
-₹18.90 (-1.37%)
1D
Last updated 14 Aug, 2026, 15:29 IST

Eris Lifesciences Share Price Today

As of 15 Aug 2026, Eris Lifesciences share price is ₹1,361.40. The stock opened at ₹1,381.00, compared to its previous close of ₹1,380.30. During today's trading session, Eris Lifesciences share price moved in the range of ₹1,356.20 to ₹1,381.00, with an average price of ₹1,368.60 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,200.00 and a high of ₹1,820.00. On the performance front, Eris Lifesciences share price has declined by 3.95% over the last six months and is down 19.35% on a year-on-year basis.

₹1,356.20
1.37% down today
₹1,381.00
1D LOW
1D HIGH

Eris Lifesciences Returns Calculator

Circuit
L
H
₹1,086.80
₹1,630.20
52-week
L
H
₹1,200.00
₹1,820.00

About Eris Lifesciences

Eris Lifesciences Share Price
ISIN
INE406M01024
Sector Market Cap
₹ 18,827.9 Cr

Eris Lifesciences Limited is an India-based pharmaceutical company. The Company is engaged in the manufacture and marketing of pharmaceutical products. The Company has a presence in major therapies like oral anti-diabetes, insulins, cardiovascular, vitamins/minerals and dermatology. Its flagship therapies include oral anti-diabetes, cardiovascular disease (CVD), and vitamins, minerals and nutrients (VMN). Its emerging therapies consist of dermatology, insulins, women’s health, central nervous system (CNS), oncology, and nephrology. Its portfolio of brands includes Glimisave, Eritel, LNBloc, Olmin, Crevast, Atorsave, Gluxit, Renerve, Zomelis, Cosvate, Tayo, Cyblex, Remylin, Tendia, Rabonik, Ginkocer, Psorid, Raricap, Serlift, and Onabet, among others. Its patient care initiatives (PCI) platform provides various healthcare solutions to its patients. The Company has a manufacturing plant located in Guwahati, Assam.

Eris Lifesciences Financial Highlights

  • Revenue: Eris Lifesciences reported revenue of ₹3,137.17 crore in FY26 vs ₹2,912.00 crore in FY25. It showed an increase of 7.73% on a yearly basis.
  • Operating Profit: Eris Lifesciences reported an operating profit of ₹638.54 crore in FY26 vs ₹488.87 crore in FY25. It showed an increase of 30.62% on a year-on-year basis.
  • Net Profit: Eris Lifesciences reported a net profit of ₹647.51 crore in FY26 vs ₹374.67 crore in FY25. It showed an increase of 72.82% on a yearly basis.

Eris Lifesciences Quarterly Result Highlights

  • Eris Lifesciences reported revenue of ₹875.64 crore in Jun 2026, compared with ₹758.79 crore in Mar 2026, representing an increase of 15.40% on a quarter-on-quarter (QoQ) basis.
  • Eris Lifesciences reported an operating profit of ₹179.49 crore in Jun 2026, compared with ₹159.41 crore in Mar 2026, representing an increase of 12.60% on a quarter-on-quarter (QoQ) basis.
  • Eris Lifesciences reported a profit of ₹143.32 crore in Jun 2026, compared with ₹279.10 crore in Mar 2026, reflecting a decrease of 48.65% on a QoQ basis.
  • The earnings per share (EPS) of Eris Lifesciences stood at ₹25.85 during Jun 2026.
Know more
Promoters
54.14%
FII
5.75%
Other DII
1.84%
Retail and other
19.40%
Mutual funds
18.88%
Foreign institutions - FII
FII shareholding by period
Sep 20257.21%
Dec 20256.85%
Mar 20266.39%
Jun 20265.75%
Mkt Cap Cr
18,827.90
P/E
28.28
P/B
4.82
ROE
15.87%
D/E
0.66
ROCE
13.27%
Div. Yield
0.52%
EPS(TTM)
17.86
Turnover
0.28
EV/EBITDA
18.98
Net Margin
0.00%
Op. Margin
0.00%
ROA
9.04%
Quick Ratio
0.00
Curr. Ratio
2.36
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
ERIS Lifescience has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
ERIS Lifescience appears overvalued compared to its peers
Step 5 of 5
Earnings
Excellent
ERIS Lifescience revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,66,155.0038.475.5813.74%0.6117.33%93.240.82%0.4810.90
Divis Laboratories2,25,648.0077.1513.4615.32%0.0019.56%629.490.35%0.5598.19
Torrent Pharmaceuticals1,84,109.0086.0322.0625.49%1.6913.85%222.760.69%0.4958.70
Cipla1,17,139.0035.173.4311.27%0.0014.95%423.360.89%0.4543.52
Zydus Lifesciences1,17,007.0025.484.3218.59%0.3117.35%237.300.09%0.3335.38
Lupin1,03,380.0018.414.5523.76%0.0424.88%659.050.80%0.57129.18
Dr. Reddy's Laboratories1,00,328.0031.522.6411.07%0.1812.54%377.960.66%0.4138.68
Mankind Pharma99,862.4048.306.1311.74%0.3413.13%397.020.04%0.4449.37
Laurus Labs98,064.0091.2318.7716.77%0.4016.14%97.200.11%0.6713.72
Aurobindo Pharma96,215.6025.932.549.25%0.1911.76%391.140.24%0.3841.58

Eris Lifesciences Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹2,893.64₹2,009.15₹1,685.15₹1,347.04
Other Income₹18.36₹23.82₹11.15₹26.09
Total Revenue₹2,912.00₹2,032.97₹1,696.30₹1,373.14
Total Expenses₹2,423.19₹1,601.63₹1,291.66₹930.94
Profit Before Tax₹488.87₹431.34₹404.64₹442.20
Tax₹114.20₹34.22₹30.48₹36.41
Profit After Tax₹374.67₹397.12₹374.16₹405.79
EPS - Basic₹25.85₹28.82₹28.10₹29.89
EPS - Diluted₹25.81₹28.79₹28.07₹29.88

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹488.87₹431.34₹404.64₹442.20
Income before WC changes₹1,036.92₹685.50₹544.48₹491.45
Change in Assets₹15.99-₹90.25-₹188.85-₹58.61
Change in Liabilities₹109.98-₹8.49₹13.32₹28.71
Change in WC₹125.97-₹98.74-₹175.54-₹29.90
Cash flow from Operations₹1,065.01₹486.01₹291.74₹378.26
Cash flow from Investing-₹79.97-₹1,854.52-₹982.10-₹319.61
Cash flow from Financing-₹881.32₹1,379.78₹688.03-₹44.70
Total Cash Flow₹103.72₹11.27-₹2.34₹13.96
Cash (Start of the year)₹94.25₹56.02₹50.87₹36.92
Cash (End of the year)₹199.74₹94.15₹56.02₹50.87

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹5,810.18₹4,738.42₹2,902.61₹1,644.81
Current Assets₹1,222.99₹2,302.04₹764.72₹627.33
Total Assets₹7,033.17₹7,040.46₹3,667.33₹2,272.14
Current Liabilities₹1,381.39₹2,532.07₹443.23₹199.65
Net Current Asset-₹158.40-₹230.03₹321.49₹427.68
Non-Current Liabilities₹2,380.02₹1,286.30₹1,003.42₹164.29
Equity Capital₹3,271.76₹3,222.09₹2,220.68₹1,908.20
Total Equity & Liabilities₹7,033.17₹7,040.46₹3,667.33₹2,272.14

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹1,697.75₹1,486.71₹1,330.73₹1,215.73
Other Income₹35.51₹34.83₹17.26₹28.99
Total Revenue₹1,733.26₹1,521.54₹1,347.99₹1,244.72
Total Expenses₹1,613.21₹1,192.70₹911.08₹786.18
Profit Before Tax₹120.05₹328.84₹436.91₹458.54
Tax₹42.66₹29.12₹38.90₹41.35
Profit After Tax₹77.39₹299.72₹398.01₹417.19
EPS - Basic₹5.69₹22.04₹29.27₹30.70
EPS - Diluted₹5.68₹22.01₹29.23₹30.70

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹120.05₹328.83₹436.91₹458.54
Income before WC changes₹513.61₹472.95₹510.61₹489.57
Change in Assets₹117.87-₹102.33-₹122.00-₹57.75
Change in Liabilities₹83.82₹39.15₹11.50₹20.49
Change in WC₹201.69-₹63.18-₹110.50-₹37.26
Cash flow from Operations₹701.86₹336.29₹322.33₹369.41
Cash flow from Investing-₹358.99-₹2,491.89-₹513.30-₹267.64
Cash flow from Financing-₹310.46₹2,160.05₹193.75-₹88.42
Total Cash Flow₹32.41₹4.45₹2.78₹13.36
Cash (Start of the year)₹51.93₹47.48₹44.70₹31.35
Cash (End of the year)₹84.34₹51.93₹47.48₹44.70

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹4,594.89₹3,473.03₹2,231.58₹1,570.41
Current Assets₹627.54₹1,876.54₹552.08₹580.01
Total Assets₹5,222.43₹5,349.57₹2,783.66₹2,150.42
Current Liabilities₹993.94₹2,261.79₹283.77₹166.24
Net Current Asset-₹366.40-₹385.25₹268.30₹413.77
Non-Current Liabilities₹1,713.59₹563.76₹278.00₹65.62
Equity Capital₹2,514.90₹2,524.02₹2,221.88₹1,918.56
Total Equity & Liabilities₹5,222.43₹5,349.57₹2,783.66₹2,150.42
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 0
Buy orders: 0%
Sell orders: 0%
Bearish
2
Neutral
6
Bullish
0
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
45.98
Neutral
ATR (14)
36.81
Neutral
STOCH(9,6)
56.77
Neutral
STOCH RSI (14)
67.01
Neutral
ADX(9)
21.28
Bearish
UO(9)
50.6
Neutral
ROC(12)
-0.75
Bearish
WillR(14)
-61.23
Neutral
Period
Simple value
Exponential vaue
5D
1374.84
1370.74
10D
1377.08
1377.93
20D
1394.58
1390.79
50D
1412.81
1400.77
100D
1386.16
1404.25
Volume trend — traded volume by day
14 Aug0L
13 Aug0L
12 Aug0L
11 Aug3L
10 Aug0L
Average1L
Compare against other stocks
Eris Lifesciences Share Price
Eris Lifesciences
Pharmaceuticals
Add Stock
Add Another

Eris Lifesciences Share Price FAQs